Navigation Links
Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, etc.) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Date:11/9/2013

Albany, New York, USA (PRWEB) November 09, 2013

According to a new market report published by Transparency Market Research "Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global companion diagnostics market was valued at USD 1.8 billion in 2012 and is expected to grow at a CAGR of 18.1 percent from 2013 to 2019, to reach an estimated value of USD 5.6 billion in 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/companion-diagnostics-market.html.

Companion diagnostics are the tests or assays which assist physicians in making efficient treatment decisions depending on the patient response to the ongoing treatment. These tests are developed either once the drug is commercialized or along with the drug in development. The diagnostic test acts as a companion to the drug under investigation and ensures the commercialization of a safer and efficient targeted therapeutic in a very cost-effective manner. The most important factors favoring growth of the global companion diagnostics market include the increasing focus of pharmaceutical manufacturers on cost reduction in drug discovery and development, and the rising demand for targeted therapies. Also, continuous exploration of biomarkers and advances in diagnostic technologies will drive the growth and acceptance of companion diagnostics worldwide.

Factors such as lack of compact regulatory guidelines for the development and commercialization of companion diagnostics, high cost of procedures, lengthy developmental and approval phases, and lack of proper reach and availability (particularly in the low income countries) are expected to hamper the ready acceptance of companion diagnostics. Currently, many in vitro diagnostics companies are focusing on the development of accurate and reliable companion diagnostics for various biomarkers.

Pharmaceutical companies are either focusing on in-house development of companion diagnostics or development in collaboration with diagnostics companies. This strategy focusing on the co-development of a drug and its companion diagnostic will prove to be advantageous over the conventional development process occurring in isolation.

Related Report : Noninvasive Prenatal Diagnostics Market
http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html

This report studies the global market for companion diagnostics from two perspectives – companion diagnostics by indication and by geography. The market for companion diagnostics by indication includes sub-segments such as breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma and others (HIV, Thalassemia). By geography, the companion diagnostics market has been divided into four regions, namely, North America, Europe, Asia-Pacific and RoW. Market size and forecast for each segment and sub-segment has been provided for the period 2011 to 2019 in terms of USD million, with 2012 as the base year.

The compounded annual growth rate (CAGR) for each market segment has been provided for the forecast period (2013 to 2019). The report also contains a section on market overview which consists of a detailed qualitative analysis of various market dynamics, such as drivers, restraints and opportunities. A section on market attractiveness analysis and Porter’s five force analysis for the companion diagnostics market has also been included.

Browse Blog: http://www.tmrblog.com/
Browse all Market Research reports: http://www.transparencymarketresearch.com

Read the full story at http://www.prweb.com/releases/2013/11/prweb11311896.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Princess Margaret breast cancer research finds new drug target companion prognostic test for hormone therapy resistance
2. Global Personalized Medicine and Companion Diagnostic Market Q2 2013 - A Strategic Analysis of Industry Trends, Technologies, Participants and Environment Research Report
3. The Perfect Travel Companion Uncovered: Launching Tisseron Lightweight Velour Bathrobes
4. Global Companion Diagnostics Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
5. BIDMC and Diagnostics For All create first low-cost, paper-based, point of care liver function test
6. Canada In Vitro Diagnostics Market Analysis and Forecasts to 2017 in New Research Report at RnRMarketResearch.com
7. Mayo Clinic and SV Bio enter strategic relationship on genome diagnostics and interpretation
8. Diagnostic Marketing Association Names Siemens Healthcare Diagnostics its 2012 Marketer of the Year
9. Advanced Mold Diagnostics Receives Angie's List Super Service Award for 4th Straight Year
10. ORNLs awake imaging device moves diagnostics field forward
11. Penn Medicines new center for personalized diagnostics unlocks cancers secrets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/16/2018)... , ... November 16, 2018 , ... ... planning, has announced the release of the best online physician assistant programs in ... affordability, and graduate outcomes. , The research organization analyzed graduate schools across the ...
(Date:11/16/2018)... ... November 16, 2018 , ... Opioid drugs are commonly prescribed for back pain and other chronic ... disrupt pain signals. The problem with these drugs, however, is that they are very addictive. ... in 2016 and 2017, more than 130 people per day died as a result of ...
(Date:11/15/2018)... ... November 15, 2018 , ... November 13, ... platelet-rich plasma (PRP) therapies to her leading selection of minimally-invasive aesthetic treatments. PRP ... all-natural revitalization for any area of the body. Atagi Plastic Surgery & Skin ...
(Date:11/15/2018)... Texas (PRWEB) , ... November 15, 2018 , ... ... (ABFRPS) and the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) have ... ABFRPS certifies plastic surgeons in the specialty field of facial plastics and reconstruction, ...
(Date:11/15/2018)... ... November 15, 2018 , ... Sift ... Winnebago Seed Fund and additional investors including Wind River Financial, a Madison-based payment ... strategic partnership with Wind River to provide a range of solutions for healthcare ...
Breaking Medicine News(10 mins):
(Date:11/15/2018)... RATON, Fla. (PRWEB) , ... November 15, 2018 ... ... has begun accepting CBD merchant account applications in the U.S. and Canadian markets. ... present setting. This change comes after a thorough review and understanding of the ...
(Date:11/15/2018)... ... , ... Triple W, an innovator of connected health devices, today announced the ... DFree®, the first wearable device for incontinence that notifies the user when it’s time ... with bladder control issues have a convenient and cost-effective alternative to disposable diapers or ...
(Date:11/15/2018)... ... November 15, 2018 , ... BayMark ... with locations in Salt Lake City and Ogden, Utah earlier this week. ... trusted provider of evidence-based treatment for opioid addiction. The Metamorphosis programs will ...
Breaking Medicine Technology: